A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma

Clinical trial NCT02837991 · TERMINATED

Trial details

NCT number: NCT02837991
Sponsor: Celldex Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma (RCC)Clear-cell Renal Cell Carcinoma Papillary Renal Cell Carcinoma Kidney Neoplasms Metastatic Renal Cell Carcinoma Ovarian Clear Cell Carcinoma

Start date: 2016-06-01
Primary completion: 2018-11-16
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.